Φορτώνει......
Uncommon response of cisplatin and etoposide for treatment of advanced medullary thyroid carcinoma
Systemic treatment of Medullary thyroid carcinoma (MTC) is currently limited to the use of a tyrosine kinase inhibitor. Cytotoxic chemotherapy is not routinely recommended in the earlier lines of treatment due to the lack of efficacy. We describe a patient with locally advanced MTC who had an uncomm...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Case Rep |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5628208/ https://ncbi.nlm.nih.gov/pubmed/29026560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1123 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|